pubmed-article:7523048 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C0025344 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C0011854 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C1413227 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C2347804 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C1561960 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C1948053 | lld:lifeskim |
pubmed-article:7523048 | lifeskim:mentions | umls-concept:C0332162 | lld:lifeskim |
pubmed-article:7523048 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:7523048 | pubmed:dateCreated | 1994-10-24 | lld:pubmed |
pubmed-article:7523048 | pubmed:abstractText | B-cells expressing CD5 are associated with the production of autoantibodies and are present at increased levels in several autoimmune diseases. The aim of this study was to investigate the relationship of these cells to the development of type I diabetes and the presence of organ and non-organ-specific autoantibodies. | lld:pubmed |
pubmed-article:7523048 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:language | eng | lld:pubmed |
pubmed-article:7523048 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7523048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7523048 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7523048 | pubmed:month | Jul | lld:pubmed |
pubmed-article:7523048 | pubmed:issn | 0149-5992 | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:WatkinsP JPJ | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:VerganiDD | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:LeslieR DRD | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:WongF SFS | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:PeakmanMM | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:HussainM JMJ | lld:pubmed |
pubmed-article:7523048 | pubmed:author | pubmed-author:SmerdonR ARA | lld:pubmed |
pubmed-article:7523048 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7523048 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:7523048 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7523048 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7523048 | pubmed:pagination | 657-64 | lld:pubmed |
pubmed-article:7523048 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:meshHeading | pubmed-meshheading:7523048-... | lld:pubmed |
pubmed-article:7523048 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7523048 | pubmed:articleTitle | CD5+ B-cells at the onset of type I diabetes and in the prediabetic period. | lld:pubmed |
pubmed-article:7523048 | pubmed:affiliation | Department of Immunology, King's College School of Medicine, London, U.K. | lld:pubmed |
pubmed-article:7523048 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7523048 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:7523048 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:7523048 | pubmed:publicationType | Twin Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7523048 | lld:pubmed |